AQST vs. CVS
Compare and contrast key facts about Aquestive Therapeutics, Inc. (AQST) and CVS Health Corporation (CVS).
Performance
AQST vs. CVS - Performance Comparison
Loading graphics...
AQST vs. CVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | -35.76% | 81.46% | 76.24% | 123.92% | -76.81% | -27.29% | -8.08% | -7.62% | -60.75% |
CVS CVS Health Corporation | -8.76% | 84.35% | -40.77% | -12.53% | -7.63% | 54.87% | -5.14% | 17.26% | -0.03% |
Fundamentals
AQST:
$506.16M
CVS:
$91.71B
AQST:
-$0.76
CVS:
$1.39
AQST:
10.31
CVS:
0.23
AQST:
$44.55M
CVS:
$402.07B
AQST:
-$15.58M
CVS:
$55.36B
AQST:
-$64.77M
CVS:
$8.69B
Returns By Period
In the year-to-date period, AQST achieves a -35.76% return, which is significantly lower than CVS's -8.76% return.
AQST
- 1D
- 2.72%
- 1M
- 3.75%
- YTD
- -35.76%
- 6M
- -25.76%
- 1Y
- 43.10%
- 3Y*
- 53.83%
- 5Y*
- -4.19%
- 10Y*
- —
CVS
- 1D
- 2.40%
- 1M
- -10.11%
- YTD
- -8.76%
- 6M
- -3.17%
- 1Y
- 10.05%
- 3Y*
- 2.77%
- 5Y*
- 2.63%
- 10Y*
- -0.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AQST vs. CVS — Risk / Return Rank
AQST
CVS
AQST vs. CVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aquestive Therapeutics, Inc. (AQST) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AQST | CVS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.48 | 0.33 | +0.15 |
Sortino ratioReturn per unit of downside risk | 1.33 | 0.60 | +0.73 |
Omega ratioGain probability vs. loss probability | 1.19 | 1.09 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.62 | 0.67 | -0.05 |
Martin ratioReturn relative to average drawdown | 1.46 | 1.66 | -0.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AQST | CVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.48 | 0.33 | +0.15 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.09 | -0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.03 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.18 | 0.31 | -0.49 |
Correlation
The correlation between AQST and CVS is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AQST vs. CVS - Dividend Comparison
AQST has not paid dividends to shareholders, while CVS's dividend yield for the trailing twelve months is around 3.70%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AQST Aquestive Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CVS CVS Health Corporation | 3.70% | 3.35% | 5.93% | 3.06% | 2.36% | 1.94% | 2.93% | 2.69% | 3.05% | 2.76% | 2.15% | 1.43% |
Drawdowns
AQST vs. CVS - Drawdown Comparison
The maximum AQST drawdown since its inception was -96.68%, which is greater than CVS's maximum drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for AQST and CVS.
Loading graphics...
Drawdown Indicators
| AQST | CVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.68% | -64.07% | -32.61% |
Max Drawdown (1Y)Largest decline over 1 year | -60.61% | -16.44% | -44.17% |
Max Drawdown (5Y)Largest decline over 5 years | -90.11% | -56.79% | -33.32% |
Max Drawdown (10Y)Largest decline over 10 years | — | -56.79% | — |
Current DrawdownCurrent decline from peak | -78.11% | -25.47% | -52.64% |
Average DrawdownAverage peak-to-trough decline | -76.93% | -19.59% | -57.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.67% | 6.66% | +19.01% |
Volatility
AQST vs. CVS - Volatility Comparison
Aquestive Therapeutics, Inc. (AQST) has a higher volatility of 14.74% compared to CVS Health Corporation (CVS) at 5.98%. This indicates that AQST's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AQST | CVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.74% | 5.98% | +8.76% |
Volatility (6M)Calculated over the trailing 6-month period | 70.13% | 23.03% | +47.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 90.06% | 30.81% | +59.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 82.76% | 29.36% | +53.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 88.43% | 28.93% | +59.50% |
Financials
AQST vs. CVS - Financials Comparison
This section allows you to compare key financial metrics between Aquestive Therapeutics, Inc. and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities